Document:

Form of Award Agreement under 2006 Long-Term Equity Incentive Plan

 Exhibit 10.20 
 AWARD AGREEMENT 
 AWARD AGREEMENT (“Agreement”) made as of the date shown below by
and between Innophos Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereof (“the Participant”). 
 Introductory Statement 
 This Agreement evidences the terms and conditions under
which (i) options to purchase (referred to individually as an “Option” and collectively as the “Options”) shares of the Company’s Common Stock, par value $0.001 per share (“Common Stock”) are being granted
and/or (ii) shares of Common Stock are being awarded (referred to individually as an “Award” and collectively as “Awards”) on a conditional or contingent basis, in each case pursuant to the Company’s benefit plan or
plans identified herein (collectively, the “Plan”). Shares of Common Stock issued upon exercise of Options under this Agreement are referred to as “Option Shares.” Shares of Common Stock issued pursuant to Awards made under this
Agreement are referred to as “Restricted Shares” or “Performance Shares,” as the case may be. Collectively, Option Shares, Restricted Shares and Performance Shares are sometimes referred to as “Shares.” Capitalized
terms used in this Agreement without definition herein are intended to have the meanings given to those terms in the applicable Plan. 
 Agreements: 
  

	1.	Granting and Exercise of Options 

  

	 	a.	Option Grants. The Company grants to the Participant Options to purchase the total number of shares of Common Stock at the per share Option Price as set forth on Schedule
A attached to this Agreement and made a part hereof. The Option Price is subject to adjustment as provided in Section 4 in connection with changes in the Company’s capitalization or otherwise as provided in the Plan. Options are
granted subject to all provisions of the Plan, except as provided otherwise in this Agreement (but only to the extent the terms of this Agreement are permitted to vary from the Plan.) Unless indicated otherwise on Schedule A, the Options are
intended to be “Incentive Stock Options” to the maximum extent permitted under the Code, and it is the parties’ intention that any ambiguities in construction be interpreted to effectuate that intent. To the extent that the Options do
not qualify as “Incentive Stock Options,” the validity of the Options shall be unaffected, and instead they shall constitute Non-qualified Stock Options. 

  

	 	b.	Exercisability/Vesting. On each date set forth on Schedule A, the Options shall vest or become exercisable with respect to the number or percentage of Option Shares
originally granted hereunder, if the Participant is has been employed by, or served in the designated position with, the Company or any of its Subsidiaries from the date of this Agreement continuously (excepting agreed upon leaves of absence and
short-term disabilities not constituting a break in service) through such date, all as specified in particular on Schedule A. 

	 	c.	Acceleration and Early Termination on Change in Control. Notwithstanding any schedule established pursuant to subsection b., if the Participant has been in service
continuously (as provided in that subsection) with the Company or a Subsidiary from the date of this Agreement until the occurrence of a Change in Control (or if the Participant’s service is terminated by the Company or a Subsidiary other than
for Cause or by the Participant for Good Reason [with the term “Good Reason” having the meaning as provided in any written employment arrangements of the Participant with the Company or any of its Subsidiaries] during the 90 day period
ending on any Change in Control), all Options that have not yet become exercisable or vested at the date of the first to occur of any Change in Control event will become exercisable and vest simultaneously with that event. The Company will use its
best efforts to notify the Participant as promptly as practicable of any Change in Control event of which it obtains knowledge, and notwithstanding any other provision of this Agreement, the calculation of periods related to any Change in Control
shall be determined from the later to occur of (i) the date of the Company notice to the Participant of any such event or (ii) the date of the consummation of the event itself. Any Options that have not been exercised by the end of the
Change in Control period as specified in Schedule A will terminate at that time, unless otherwise determined by the Board. 

  

	 	d.	Expiration and Termination. The Options will expire on the earliest to occur of (i) the date or dates established in Schedule A, (ii) the final date under, or
computed in accordance with the Plan, by which all Options must expire, (iii) the date (or dates if more than one is provided) that equal the number of days following termination of the Participant’s employment or other affiliation with
the Company and its Subsidiaries as specified for “post-termination” exercise in Schedule A, or (iv) the date calculated for the end of the Change in Control period in Schedule A. In any conflict among dates calculated pursuant to
clause (i), (iii) or (iv) of this subsection d., the result yielding the latest date for the Participant shall control; provided, that the date determined under clause (ii) of this paragraph will control all other dates as the
date by which all Options must expire. 

  

	 	e.	Rules and Procedures for Exercise. Any exercise of an Option must comply with the terms and conditions respecting exercise set forth in the Plan, this Agreement and any forms
and other documents established by the Committee for use in exercising Options. 

  

	2.	Granting and Settlement of Performance Share Awards 

  

	 	a.	Award of Performance Shares. The Company awards to the Participant the number of Target Performance Shares for the Performance Cycle set forth on Schedule B attached
to this Agreement and made a part hereof. Except as otherwise provided by the Plan or this Agreement, each Performance Cycle shall commence on January 1 of the year and end on December 31 of the year indicated in the cycle.

  

	 	b.	Performance Measures and Amount of Award Earned. The Performance Measures for the Performance Cycle established for the Awards made in subsection a. are set forth in, or
referenced by, Schedule B. The amount of each Award earned relative to the number of Target Performance Shares awarded shall depend on the relative degree to which the Performance Measures, as certified in writing by the Committee, are met, equaled
or exceeded (including interpolations, if any) as set forth in, or referenced by, Schedule B. To the extent not set forth in Schedule B, documentation setting forth all Performance Measures and effects on the number of Target Performance Shares will
be furnished to the Participant. Performance Shares are deemed to be earned only upon the completion of a Performance Cycle; provided that any termination of the Plan under which Performance Shares have been awarded prior to the normal expiration of
the cycle will be deemed to be the completion of the cycle. 

  

 2 

	 	c.	Dividends. The number of Target Performance Shares will be increased each quarter during a Performance Cycle by the amount of any dividends paid by the Company in the form of
Common Stock on a like number of shares for that quarter. An amount equivalent to dividends paid by the Company in cash (or the Fair Market Value of those paid in stock other than Common Stock or in kind) will be accrued for the period covered by
each Performance Cycle on the number of Performance Shares ultimately issued (including those added by reason of the operation of the preceding sentence) and paid, without compounding or interest (except as specifically provided in this Agreement),
upon settlement of the Award. 

  

	 	d.	Settlement and Timing of Award Payouts. In settlement of its obligations for Awards under this Agreement, the Company shall deliver to the Participant:

  

	 	i)	one share of Common Stock for each Performance Share earned as determined in accordance with the provisions of this Agreement (with fractional shares of Common Stock rounded up to
the nearest whole share); 

  

	 	ii)	an amount in cash representing the dividend equivalents as computed in accordance with subsection c.; and 

  

	 	iii)	an amount in cash representing any other sums due under this Agreement. 

 Settlement shall be made prior to the last day in February in the calendar year following the last calendar year to occur in each Performance Cycle, provided that settlement shall occur no later than 60 days following any completion of a
Performance Cycle other than on the last day of a calendar year. For any Participant who is a “specified employee” within the meaning of Section 409A (a)(2)(B)(i) of the Code who is entitled to a payment under the circumstances
described in subsection e. iii. or subsection e. iv. below that constitutes deferred compensation subject to Section 409A, settlement shall be made upon the later of (a) the settlement date that otherwise applies under the preceding
sentence or (b) the date that is six months after the date that the Participant terminates employment with the Company or, if earlier, the Participant’s date of death. For payouts made under the eligibility conditions set forth in
subsection e. ii. involving a Change in Control, in subsection e. iii. or subsection e. iv, simple interest shall accrue and be paid in cash based on the Fair Market Value at the time of payment of the Award so determined under the applicable
clause, calculated from the effective date of the Change of Control to the date of payment and based on the applicable federal “short-term rate” determined under Section 1274(d) of the Code in effect on the date the Change in Control
occurs. 
  

	 	e.	Eligibility for Payout. A Participant shall be eligible for a payment of earned Performance Shares and any other property only if: 

  

	 	i)	The Participant’s employment with the Company or any Subsidiary continues through the end of the Performance Cycle, in which instance the Participant will have earned the
number of Performance Shares and any other property as calculated under subsections b. and c.; 

  

	 	ii)	 The Participant’s employment with the Company or any Subsidiary is terminated due to death, Disability or Retirement during a Performance Cycle, in which
instance the Participant will have earned a fraction of the number of Targeted Performance Shares and any other property over the complete Performance Cycle as calculated under subsections b. and c., determined using a numerator that equals the
number of complete calendar months elapsed since the beginning of the Performance Cycle through the 

  

 3 

	 	 
Participant’s date of employment termination, and a denominator that equals the total number of months in the Performance Cycle through its completion.
A Participant’s month of employment termination will be considered a complete month if the effective date of termination occurs on or after the 15th day of that month. In the event of a Participant’s death, the Participant’s
beneficiary or estate shall be entitled to the Performance Shares and other property to which the Participant otherwise would have been entitled under the same conditions as would have been applicable to the Participant; provided, however, if
the Participant’s employment is terminated due to death, Disability or Retirement and subsequently there occurs during the Performance Cycle a Change in Control where the Company is not the surviving entity, the Participant’s entitlement
fraction shall be calculated as above, but the number of Performance Shares against which the fraction shall be applied shall be those derived under clause iii.) of this subsection e.; 

  

	 	iii)	There occurs during the Participant’s employment a Change in Control where the Company is not the surviving entity, in which instance the Participant will be deemed to have
earned the greater of: (i) 100% of the Target Performance Shares granted to the Participant in subsection a. and such other property resulting from the application of subsection c. determined as of the effective date of such Change in
Control; or (ii) the number of Performance Shares that would have been earned from the application of subsection b. and such other property resulting from the application of subsection c. that would have been earned by the Participant if the
Performance Cycle had been completed on the effective date of the Change in Control; or 

  

	 	iv)	There occurs a Change of Control during a Performance Cycle where the Company is the surviving entity, and within two years after the effective date of such Change in Control, the
Participant’s employment is terminated by the Company or any Subsidiary other than for Cause or by the Participant for Good Reason, in which instance the Participant will be deemed to have earned amounts determined according to clause iii
above. 

  

	 	f.	Termination for Other Reason. In the event that the Participant’s employment terminates during a Performance Cycle for any reason other than those reasons set forth in
subsection e., the entire Award shall be forfeited, and no payment shall be made to the Participant. 

  

	3.	Granting of Restricted Share Awards. The Company awards to the Participant the number of Restricted Shares set forth on Schedule C attached to this Agreement and made
a part hereof. Such Restricted Shares shall be issued to the Participant following the effectiveness of this Agreement, and, upon issuance, shall constitute duly and validly issued and outstanding Shares of the Company, fully paid and
non-assessable. Shares for which restrictions lapse as provided in Schedule C or herein shall be vested entirely in the Participant. Shares for which restrictions do not so lapse as and when provided in Schedule C or herein shall be forfeited back
to the Company, and, thereafter, the Participant shall have no further property rights in, or claims to, such Shares. A grant of Restricted Shares shall be treated by the Company as subject to tax under Section 83 of the Internal Revenue Code,
and not as a plan of deferred compensation. 

  

	 	a.	Record Holder. Restricted Shares shall be issued and registered in the name of the Participant. Prior to any forfeiture of Restricted Shares, the Participant shall be treated
as the holder of record of such Shares for all purposes under applicable corporate law, including receiving all dividends and other distributions to which such holders are entitled and receiving notice of, and voting on or consenting to, all matters
which are properly submitted to the stockholders of the Company for determination by them. 

  

 4 

	 	b.	Shares to be Held in Escrow. Unless otherwise permitted by the Committee, Restricted Shares shall be held by the Company or its agents in escrow for delivery to the
Participant upon the lapse of all risks of forfeiture relating to such Shares (or portions thereof) and the satisfaction of all other conditions, if any, to delivery of such Shares, all as set forth on Schedule C to the extent not set forth herein.
Delivery of such Shares from escrow shall be in such form and with such further restrictions as the Company may reasonably require as necessary to comply with applicable law. 

  

	 	c.	Change in Control. If the Participant has been in active service with the Company or a Subsidiary (to the extent required by Schedule C) from the date of this Agreement until
the occurrence of a Change in Control (or if the Participant’s service is terminated by the Company or a Subsidiary other than for Cause or by the Participant for Good Reason, in the case of a Participant who then has an employment agreement
with the Company which addresses termination by the Participant for Good Reason, with the term “Good Reason” having the meaning set forth in such employment agreement) within two years after the effective date of such Change in Control,
then, notwithstanding Schedule C, all other conditions to vesting of Restricted Shares shall be deemed to have been satisfied, all forfeiture restrictions shall lapse, and all Restricted Shares covered by this Agreement, to the extent not previously
vested, shall vest in the Participant. The Company will use its best efforts to notify the Participant as promptly as practicable of any Change in Control event of which it obtains knowledge, and notwithstanding any other provision of this
Agreement, the calculation of periods related to any Change in Control shall be determined from the later to occur of (i) the date of the Company notice to the Participant of any such event or (ii) the date of the consummation of the event
itself. 

  

	4.	Schedules Form Part of Agreement. Schedule A, Schedule B, Schedule C and the other schedules, if any (including their respective attachments, if any), which shall be
identified sequentially as “D, “ “E,” etc., attached to this Agreement form an integral part of this Agreement and are incorporated herein by reference as if set out at length in the body of this Agreement. In the event of any
inconsistency between any schedule and the remainder of this Agreement, the text of the schedule in question (including any calculation) shall be deemed to control. The grant of Options and Awards specified in this Agreement is being made in
consideration, among other things, of the Participant’s compliance with the terms of the schedules. This Agreement and all schedules are governed by the terms of the Plan under which the Options or Awards are granted; provided, however,
where the Plan permits the terms of an Award Agreement to differ from any Plan provision, the terms of this Agreement shall be deemed control the rights of the parties as to that provision. 

  

	5.	Continuity of Shares and Adjustments. For all purposes of this Agreement, Option Shares and Performance Shares (prior to issuance) include shares of Common Stock and the
Company’s capital stock of any class or series issued with respect to Common Stock by way of a stock split, stock dividend, reclassification or other recapitalization to the fullest extent permitted by the Plan. The exercise price of Options
granted under this Agreement, the number of Option Shares issuable in respect of Options and the number of Performance Shares issuable in respect of Awards shall be subject to equitable adjustment by the Company as a result of any of the events
referred to in this section or those determined in the absolute discretion of the Company to be analogous thereto; provided, that all such adjustments shall be made equally and ratably among all Participants as to the Plan involved.

  

	6.	 Non-Transferability of Options and Awards. The Options and Awards are personal to the Participant and may not be sold, transferred, pledged, assigned, or
otherwise alienated or hypothecated (a “Transfer”) other than by will or by the laws of descent and distribution, except 

  

 5 

	 	 
to the extent specifically provided in the Plan. Only the Participant or the Participant’s permitted representatives are entitled to exercise Options.
If any non-permitted Transfer, whether voluntary or involuntary, of Options or Awards is made or attempted, or if any attachment, execution, garnishment, or lien shall be issued against or placed upon Options or Awards, as the case may be, the
Participant’s right to such property shall be forfeited immediately to the Company, and this Agreement shall lapse as to such property. Notwithstanding the previous sentence, the Participant’s obligations under this Agreement shall survive
any such forfeiture and lapse. 

  

	 7.
	 No Rights as to Relationship. This Agreement shall not confer upon the Participant any right to continuation of
employment by the Company or any Subsidiary, nor will this Agreement interfere in any way with any such employer’s rights to terminate the Participant’s employment at any time. The grant of Options or Awards of Performance Shares shall
confer no rights on the Participant as a stockholder until such time as the related Shares are issued.1 

  

	8.	Tax and Stock Withholding. The Company shall have the power and the right to deduct or withhold, or require the Participant or the Participant’s beneficiary to remit to
the Company, an amount sufficient to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of this Agreement. With respect to withholding
required upon any taxable event arising as a result of Options or Awards granted hereunder, the Company shall satisfy the tax withholding requirement by withholding Shares having a Fair Market Value equal to the total minimum statutory tax required
to be withheld on the transaction. The Participant agrees to pay to the Company /or its Subsidiaries any amount of tax that the Company or such Subsidiary may be required to withhold as a result of the Participant’s participation in the Plan
that cannot be satisfied by the means previously described. 

  

	9.	Share Issuances and Sales Subject to Requirements of Law. 

  

	 	a.	The granting of Options and Awards under the Plan and the issuance of Shares shall be subject to all applicable laws, rules, and regulations, and to such approvals by any
governmental agencies or national securities exchanges as may be required. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the
lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability with respect to the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained. 

  

	 	b.	The Participant understands and acknowledges that federal and state securities laws govern and restrict the Participant’s right to offer, sell or otherwise dispose of Shares,
unless that offer, sale or other disposition thereof is registered under the Securities Act of 1933 (the “1933 Act”) and state securities laws or, in the opinion of the Company’s counsel, such offer, sale or other disposition is
exempt from registration thereunder. The Participant agrees that he or she will not offer, sell or otherwise dispose of Shares in any manner that would: (i) require the Company to file any registration statement (or similar filing under state
law) with the Securities and Exchange Commission or to amend or supplement any such filing or (ii)

  
  

	 1
	 For employees of subsidiaries in Mexico, the additional following language applies to this section: “By signing
this Agreement, any Participant who is employed by a Subsidiary and renders personal services to that Subsidiary agrees that this Agreement and the Plan do not create any form of labor relationship between such Participant and the Company, as the
rights granted under this Agreement are a consequence of the personal relationship between the Participant and the Subsidiary.” 

  

 6 

 violate or cause the Company to violate the 1933 Act, the rules and regulations promulgated thereunder or
any other state or federal law. The Participant further understands that the certificates for Shares that the Participant receives will bear such legends as the Company deems necessary or desirable in connection with the 1933 Act or other rules,
regulations or laws. 
  

	10.	Amendments to Plan and Agreement. The Plan is discretionary in nature and the Company may terminate, amend, or modify the Plan to the fullest extent provided therein;
provided, however, that no such termination, amendment, or modification of the Plan may in any way adversely affect the Participant’s rights under this Agreement, without the Participant’s written approval. The Company may
terminate, amend, or modify this Agreement; provided, however, that any amendment and/or termination of this Agreement will not subject such amounts payable under this Agreement to penalties and interest under Code Section 409A.
Additionally, no such termination, amendment, or modification of this Agreement may in any way adversely affect the Participant’s rights under this Agreement, without the Participant’s written approval. 

  

	11.	Administration. This Agreement and the Participant’s rights hereunder are subject to all the terms and conditions of the Plan, as the same may be amended from time to
time, as well as to such rules and regulations as the Committee may adopt for administration of the Plan. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to
the administration of the Plan and this Agreement, all of which will be binding upon the Participant, subject to rights expressly conferred on the Participant under Section 10. 

  

	12.	Notices. Any notice given in connection with this Agreement must be in writing and must be personally delivered, received by certified mail, return receipt requested, or sent
by guaranteed overnight delivery service or facsimile where a receipt can be procured, to the parties at the addresses indicated below: 

 If to the Company/Committee, to: 
 Innophos Holdings, Inc. 
 P.O. Box 8000 
 259 Prospect Plains Road 
 Cranbury, NJ 08512-8000 
 Fax: (609) 860-0350 
 Attn: Vice President—Human Resources 
 If to the Participant, to: 
 The address set forth on the signature 
 page of this Agreement 
 or such other address or to the attention of such other person as the recipient party shall have
specified by prior written notice to the sending party. Any notice under this Agreement will be deemed to have been given when so delivered or mailed. 
  

 7 

	13.	Representations and Warranties. 

  

	 	a.	Participant’s Representations and Warranties. The Participant represents and warrants to the Company that: 

  

	 	i)	This Agreement constitutes the legal, valid and binding obligation of the Participant, enforceable against the Participant in accordance with its terms, and the execution, delivery
and performance of this Agreement by the Participant does not and will not conflict with, violate or cause a breach of any agreement, contract or instrument to which the Participant is a party or any judgment, order or decree to which the
Participant is subject; 

  

	 	ii)	Unless Options being granted hereunder are not Incentive Stock Options, the Participant, as of the date hereof, does not own stock possessing more than 10% of the total combined
voting power of all classes of stock of the Company or any parent or Subsidiary of the Company; and 

  

	 	iii)	The Participant will review all disclosure materials provided by the Company in connection with the offering of Shares to the Participant under the 1933 Act.

  

	 	b.	Company Representations and Warranties. The Company represents and warrants to the Participant that: 

  

	 	i)	This Agreement constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, and the execution, delivery and
performance of this Agreement by the Company does not and will not conflict with, violate or cause any breach of any agreement, contract or instrument to which the Company is a party or any judgment, order or decree to which the Company is subject.

  

	14.	Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision
of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or the effectiveness or
validity of any provision in any other jurisdiction. 

  

	15.	Complete Agreement and Certain Priorities. This Agreement and the Plan embody the complete agreement and understanding between the parties with respect to Options and Awards
and supersede and preempt any prior understandings or agreements between the parties, written or oral, with regard to that subject matter. In the event any Schedule to this Agreement pertains to obligations of the Participant as an employee, other
agent or contractor regarding confidentiality or restrictions relating to employment, proprietary rights, competition and other employment-related practices, this Agreement shall be deemed to supersede any prior or subsequent understanding or
agreement between the Company and the Participant as to that subject matter only to the extent that the provisions, if any, set forth in this Agreement are more restrictive upon the Participant than such other understanding or agreement.

  

	16.	Counterparts. This Agreement may be executed in separate counterparts (including by means of facsimile), each of which will be deemed to be an original and all of which taken
together will constitute one and the same agreement. 

  

	17.	Successors and Assigns. This Agreement is intended to bind and inure to the benefit of and be enforceable by the Participant and the Company and their respective successors
and assigns, including without limitation as to the Company whether the existence of such successor or assign is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or
assets of the Company and as to the Participant whether such successor or assign results from the laws of descent and distribution; provided, that the Participant may not assign any of his or her rights or obligations, except as expressly
provided by the terms of this Agreement or the Plan. 

  

 8 

	18.	Governing Law. The corporate law of the State of Delaware will govern all issues concerning the relative rights of the Company and its stockholders. All other issues
concerning the enforceability, validity and binding effect of this Agreement will be governed by, and construed in accordance with, the laws of the State of New Jersey, without giving effect to any choice of law or conflict of law provision or rule
that would cause the application of the law of any jurisdiction other than the State of New Jersey. 

  

	19.	Enforcement Matters. 

  

	 	a.	Except as may be otherwise provided in this Agreement, all disputes and controversies arising under or in connection with this Agreement shall be settled by arbitration conducted in
accordance with the arbitration procedures described in this section. Except as otherwise provided in the JAMS’ Comprehensive Arbitration Rules and Procedures as in effect from time to time (the “JAMS Rules”), the arbitration
procedures described in this section and any Final Arbitration Award (as defined below) will be governed by, and will be enforceable pursuant to, the Uniform Arbitration Act as in effect in the State of New Jersey from time to time. Arbitral
proceedings initiated hereunder shall take place in Cranbury, NJ, or another place agreeable to the parties to the dispute, before a single arbitrator who is agreeable to such parties. If the parties are unable to agree on an arbitrator within a
reasonable period of time, an arbitrator shall be selected in accordance with the JAMS Rules. The arbitration (including discovery) will be conducted under the JAMS Rules, as the same may be modified by any written agreement between the parties to
the dispute. The arbitrator will conduct the arbitration in a manner so that the final result, determination, finding, judgment or award determined by the arbitrator (the “Final Arbitration Award”) is made or rendered as soon as
practicable, and the parties to the dispute will use reasonable efforts to cause a Final Arbitration Award to occur within ninety (90) days after the arbitrator is selected. Any Final Arbitration Award will be final and binding upon the parties
to the dispute, and there will be no appeal from or reexamination of any Final Arbitration Award, except in the case of fraud or perjury or misconduct by the arbitrator prejudicing the rights of any party to the dispute or to correct manifest
clerical errors. A Final Arbitration Award may be enforced in any state or federal court having jurisdiction over the subject matter of the dispute. Each party to the dispute shall bear and be solely responsible for all costs and expenses (including
fees and disbursements of counsel) incurred by such party in connection with any arbitration conducted hereunder, and the costs and expenses of the arbitrator shall be borne 50% by the Company and 50% by the Participant. 

  

	 	b.	Except to the extent required by subsection a., for the purpose of litigating disputes that arise under this Agreement, the parties hereby consent to exclusive jurisdiction and
agree that such litigation will be conducted in the federal or state courts of the State of New Jersey sitting in and for the county wherein the headquarters of the Company is located at the time. To effect the foregoing, the Participant hereby
subjects himself or herself to the in personam jurisdiction of such courts and waives all objections as to improper venue for such forum posited as provided in the preceding sentence. 

  

 9 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year written below. 
 Date:
                                         
    
  

			
	INNOPHOS HOLDINGS, INC.
		
	By:	 	 
		
	Name:	 	 
		
	Title:	 	 
	
	PARTICIPANT
		
	Name:	 	 
		
	Signature	 	 
		
	Address:	 	 
		
		 	 
		
	Telephone:	 	 
		
	Fax:	 	 
		
	E-mail:	 	 

 [balance of page left blank intentionally] 
  

 10 

 Schedule A 
 to 
 Award Agreement 
 (OPTIONS) 
 Name of Participant:
                                         
    
  

	1.	Name of Governing Plan:
                                        

  

	 	a.	Number of Option Shares:
                                        

  

	 	b.	Option Price:
                                        

  

	 	 c.
	 Grant Date (if different from Agreement Date)
                                         
           2 

  

	 	d.	 ̈ Check Box if Non-Qualified Options 

  

	 	e.	 ̈ Check Box if Option Price is Greater than Fair Market Value 

  

	2.	Vesting/Exercisability: 

 [insert
details, table or use Attachment A1] 
  

	3.	Expiration
Date(s):                                       
                  

  

	 	a.	Post-termination Days for Exercise:
                                         
                    

 [insert
separate number associated with each particular cause of termination, as applicable or use Attachment A1] 
  

	 	b.	Change in Control Period:
                                        
             

  

	 	c.	Form of Notice of Exercise: 

 Options must be
exercised on the prescribed form. 
 See Attachment A2 which forms part of this Schedule 
  

							
				
	  	 	[initial]	 	  	 	[initial]
	For the Company	 		 	Participant	 	

  

	 2
	 Note: Insertion of a date here requires written evidence of action establishing a grant on the date
inserted. 

  

 A1 

 Schedule B 
 to 
 Award Agreement 
 (PERFORMANCE SHARES) 
 Name of Participant:
                                         
            
  

	1.	Name of Governing Plan:
                                         
    

  

	2.	Number of Target Performance Shares
                                    

  

	3.	Performance Cycle
                                        
 

  

	4.	Performance Measure(s): 

 [insert details, table or
use Attachment B1] 
  

							
				
	  	 	[initial]	 	  	 	[initial]
	For the Company	 		 	Participant	 	

 Schedule C 
 to 
 Award Agreement 
 (RESTRICTED SHARES) 
 Name of Participant:
                                     
  

	1.	Name of Governing Plan:
                                         
            

  

	2.	Number of Restricted Shares:
                                         
    

  

	3.	Conditions to Vesting, Lapse of Forfeiture or Delivery: 

 [insert details, table or use Attachment C1] 
 The Participant acknowledges that the Participant may be eligible to file an election with the
Internal Revenue Service under Section 83(b) of the Internal Revenue Code within 30 days following the date of grant of Restricted Shares, and that failure to do so may irrevocably affect the tax treatment of the Restricted Shares granted to
the Participant. 
  

							
				
	  	 	[initial]	 	  	 	[initial]
	For the Company	 		 	Participant	 	

 Attachment C1 

 Schedule D 
 to 
 Award Agreement 
  

	 ̈	CHECK HERE IF THIS SCHEDULE IS APPLICABLE AND INITIAL LAST PAGE OF SCHEDULE 

 Name of Participant:
                                         
                    
 Restrictive
Covenants and Enforcement 
  

	1.	Noncompete Period. 

 The term “Noncompete Period” shall
mean the period (i) commencing on the date the Participant’s employment or similar relationship with the Company and its Subsidiaries or other entities controlled directly or indirectly by either (collectively, “controlled
affiliates”) began and (ii) ending after the passage of the number of full calendar months indicated below from the date on which the Participant’s employment or similar relationship with the Company or any of its controlled
affiliates is effectively terminated. 
                 
months [fill in ] 
  

	2.	Confidential Information. 

  

	 	a.	 The Participant acknowledges that the information, observations and data, including trade secrets, obtained by the Participant while employed or retained by
the Company and its controlled affiliates concerning their business and affairs (collectively, “Confidential Information”) are the property of those entities. Therefore, the Participant agrees that, except as required by law, court order
or other legal process, including, but not limited to, depositions, interrogatories, court testimony, arbitration, and the like, the Participant shall not disclose to any unauthorized person or use for his own purposes any Confidential Information
without the prior written consent of the Company’s Board of Directors (which may delegate to an authorized officer authority to give such consent), unless and to the extent that: (i) the Confidential Information becomes generally known to
and available for use by the public or generally known in the industry other than as a result of the Participant’s acts or omissions or (ii) the Participant discloses such information to third parties with whom the Company or its
affiliates have entered into a non-disclosure agreement and such disclosure is made in the ordinary course performance of the Participant’s duties and responsibilities to the Company and its affiliates. The Participant shall deliver to the
Company at the termination of his employment or other similar relationship, or at any other time the Company may 

	 	 
request, all memoranda, notes, plans, records, reports, computer tapes, printouts and software and other documents and data (and copies thereof) embodying or
relating to the Confidential Information, Work Product (as defined below) or the business of the Company and its controlled affiliates which the Participant may then possess or control, provided that the Participant may retain a copy of contact
information consisting of names, telephone numbers and other contact details relating to outside parties so long as the Participant does not use such material in a manner that is otherwise prohibited by this Agreement. 

 

	 	b.	The Participant represents and warrants to the Company that the Participant took nothing with him that belonged to any former employer when the Participant left his prior
position or that the Participant has nothing that contains any information which belongs to any former employer that the Participant is not entitled to have or use for the benefit of the Company and its controlled affiliates. If at any time the
Participant discovers that the foregoing statement is incorrect, the Participant shall promptly return any such materials to the Participant’s former employer or obtain any necessary consents. The Participant understands that Company does not
want any such materials, and that the Participant will not be permitted to use or refer to any such materials in the performance of the Participant’s duties. 

  

	3.	Intellectual Property, Inventions and Patents 

 The Participant
acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential
information) and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not patentable) which (i) relate to the Company’s or any of its controlled
affiliate’s actual or anticipated business, research and development or existing or future products or services and (ii) are conceived, developed or made by the Participant (whether individually or jointly with others) while employed by
the Company or its affiliates or their predecessors in interest (collectively, “Work Product”), belong to the Company or such affiliate, as the case may be. The Participant shall disclose Work Product promptly to the Company or the
applicable affiliate in the manner required under procedures established by those entities and, at the expense of the Company or applicable affiliate, as the case may be, perform all actions reasonably requested on behalf of any such entity (whether
during or after any period of employment or engagement) to establish and confirm such ownership (including, without limitation, assignments, consents, powers of attorney and other instruments). 
  

	4.	Non-competition; Non-solicitation. 

  

	 	a.	 Non-competition. The Participant acknowledges that, during the course of the Participant’s employment or similar engagement with the Company and
its controlled affiliates (including their respective predecessors in interest), the Participant has or will become familiar with the trade secrets of, and other Confidential Information concerning, those entities and that the Participant’s
services have been, and are reasonably expected to be, of special, unique and extraordinary value to the Company and its affiliates. As a result, the Participant agrees that, during the Noncompete Period, the Participant shall not directly or
indirectly own any interest in, manage, control, participate in, be employed by, consult with, render services for, or in any manner engage in any Competing Business within any geographical area in which the Company or any of its controlled
affiliates engage or plan to engage in such businesses. Nothing herein shall prohibit the Participant from owning beneficially not more than 2% of any class of outstanding equity securities or other comparable interests of any issuer that is
publicly traded, so long as the Participant has no active participation in the business of such issuer. For purposes hereof, the term “Competing Business” means any business that is 

	 	 
engaged in the production, distribution or sale of products that compete with the products produced, distributed or sold by the Company or its controlled
affiliates (or are in the process of being developed by such entities) as of the date on which the Participant’s employment or similar relationship with the Company or any of its controlled affiliates is effectively terminated. This restriction
shall not prevent the Participant from working for a subsidiary, division, venture or other business unit (collectively a “Unit”) of a Competing Business so long as (i) such Unit is not itself a Competing Business, (ii) the
Participant does not manage or participate in business activities or projects of any Unit that is a Competing Business, and (iii) the Participant otherwise strictly complies with the restrictive covenants contained in this schedule.

  

	 	b.	Non-solicitation. During the Noncompete Period, the Participant shall not directly or indirectly through another person or entity: (i) induce or attempt to induce
any executive or other key employee of the Company or any controlled affiliate to leave the employ of any of those entities, or in any way interfere with the relationship between the Company or any such affiliate and any such person; (ii) hire
or offer to hire any person who was an executive or other key employee of the Company or any controlled affiliate at any time within the one year period prior to an offer of employment to such person; or (iii) induce or attempt to induce any
customer, supplier, licensee, licensor, franchisee or other business relation of the Company or any controlled affiliate to cease doing business with any Company-affiliated entity, or in any way interfere with the relationship between any such
customer, supplier, licensee or business relation and Company-affiliated entity. The foregoing restriction will not preclude the Participant from (a) providing customary business references for Company executives or other key employees at their
request, (b) being involved in a general solicitation to the public of general advertising, or (c) engaging or participating in solicitations by recruiting consultants not specifically targeted at the Company or its Subsidiaries or
Affiliates. 

  

	5.	Nature of Restrictive Covenants; Enforcement. 

  

	 	a.	For purposes of enforcement, the restrictive covenants contained in this schedule are independent of any other provision of this Agreement. As a result, the existence of any
claim or right of set-off that the Participant may have or allege against the Company, whether based on this Agreement or otherwise, shall not prevent the enforcement of the covenants or be deemed to mitigate any harm suffered by the Company.

  

	 	b.	 Because the Participant’s services are unique (resulting in the Company’s need for the restrictions in this schedule) and because the Participant
has access to Confidential Information, Work Product and other proprietary resources representing valuable assets of the Company, the parties agree that the Company and its affiliates would suffer irreparable harm from a breach or threatened breach
by the Participant of the restrictions set forth in this schedule and that money damages would not be an adequate remedy for any such non-compliant conduct. Therefore, notwithstanding the methods prescribed elsewhere in this Agreement for the
enforcement of its provisions, in the event of a breach or threatened breach of the restrictive covenants in this schedule, the Company (including its affected affiliates and their respective successors or assigns) in addition to other rights and
remedies existing in their favor, shall be entitled to specific performance and/or injunctive or other equitable relief from a court of competent jurisdiction in order to enforce, or prevent any violations of, the provisions in this schedule
(without posting a bond or other security, any requirement of which is waived by the Participant). In the event of any breach by the Participant of the restrictions set forth in this schedule, the Noncompete Period shall be tolled 

	 	 
until such breach has been cured. If, at the time of enforcement, a court holds that restrictions contained in this schedule are unreasonable under
circumstances then existing, the parties agree that the maximum period, scope or geographical area reasonable under such circumstances (or as otherwise allowed by governing law) are to be substituted for the stated period, scope or area provided in
this schedule, and the restrictions are to be deemed reformed to that extent. 

 The Participant acknowledges that the
restrictions contained in this schedule are reasonable and that the Participant has had the opportunity to review them and the other provisions of this Agreement with legal counsel and such other advisors as the Participant deems appropriate.

  

							
				
	  	 	[initial]	 	  	 	[initial]
	For the Company	 		 	ParticipantExhibit 10.8.2

 Exhibit 10.8.2 
 EXECUTIVE CONFIDENTIALITY, NON-SOLICITATION, 
 NON-COMPETITION AND SEVERANCE AGREEMENT

 THIS EXECUTIVE CONFIDENTIALITY, NON-SOLICITATION, NON-COMPETITION AND SEVERANCE AGREEMENT (together with the annexes and exhibit
attached hereto, this “Agreement”) is entered into as of the date set forth on the signature page hereto between PAETEC Holding Corp., a Delaware corporation (“PAETEC Holding”), and
                     (“you”). 
 WHEREAS, the Company (as defined herein) has developed and expects to continue to develop confidential and proprietary materials and highly sensitive information of significant value, which you recognize must be carefully protected as set
forth below for the Company to be successful; 
 NOW, THEREFORE, to induce the Company to continue to employ you, and in consideration of
your continued employment by the Company and for other good and valuable consideration, the receipt and sufficiency of which you hereby acknowledge, PAETEC Holding and you hereby agree, intending to be legally bound, as follows: 
  

	1.	Defined Terms 

 For purposes of this Agreement, the
following capitalized terms have the meanings ascribed to such terms in this Section 1: 
 “Affiliate” shall have the
meaning ascribed to such term in Rule 12b-2 promulgated under the Exchange Act. 
 “Board” shall mean the board of directors
of PAETEC Holding. 
 “Cause” shall mean termination of your employment with the Company due to any of the following:
(a) your material failure or refusal to perform the duties assigned to you, provided that the Company gives you a written notice of your failure or refusal to perform such duties and 20 days to remedy such failure or refusal, and
provided, further, that such duties are not materially inconsistent with those of other individuals who report directly to the officer of the Company to whom you directly report (or materially inconsistent with those of other individuals
reporting directly to the Board, if you are the Chief Executive Officer of PAETEC Holding); (b) your refusal to follow the reasonable directives of the Board, the Chief Executive Officer or the other officer to whom you directly report,
provided that the Company gives you a written notice of your refusal to perform such directives and 20 days to remedy such refusal, and provided, further, that such directives are not materially inconsistent with those of other
individuals who report directly to the officer of the Company to whom you directly report (or the Board, if you are the Chief Executive Officer of PAETEC Holding); or (c) your conviction of a felony. 

 “Change of Control Transaction” shall mean any of the following: 
  

	 	(a)	the dissolution or liquidation of PAETEC Holding; 

  

	 	(b)	a merger, consolidation, reorganization or similar transaction involving PAETEC Holding (i) in which PAETEC Holding is not the surviving corporation or other surviving Person
or (ii) which results in PAETEC Holding becoming the wholly-owned subsidiary of another corporation or other Person (any transaction of the type specified in this clause (ii), a “Parent Transaction”), unless the Existing Stockholders
beneficially own (within the meaning of Rule 13d-3 promulgated under the Exchange Act) in the aggregate immediately following the consummation of such transaction more than 50% of the combined voting power of all classes of outstanding Voting
Securities of the successor to PAETEC Holding (in the case of a transaction referred to in clause (i) above) or of the corporation or other Person whose Voting Securities are issued to the Existing Stockholders in such transaction (in the case
of a transaction referred to in clause (i) or (ii) above); 

  

	 	(c)	a sale of all or substantially all of the assets of PAETEC Holding to another corporation or other Person, as determined in accordance with the applicable law of the State of
Delaware; 

  

	 	(d)	any other transaction (including a merger, consolidation, reorganization or similar transaction) that results in any corporation or other Person, other than the Arunas A. Chesonis
and his controlled Affiliates, beneficially owning (within the meaning of Rule 13d-3 promulgated under the Exchange Act) immediately following the consummation of such transaction more than 50% of the combined voting power of all classes of
outstanding Voting Securities of (i) the corporation (including, to the extent applicable, PAETEC Holding) or other Person whose Voting Securities are issued to the Existing Stockholders in such transaction or (ii) if no such issuance is
made in such transaction, PAETEC Holding; or 

  

	 	(e)	 the Incumbent Board Members ceasing for any reason to constitute (i) at any time prior to the consummation of a Parent Transaction, a majority of the Board or
a majority of the board of directors, board of managers or other governing body of any successor to PAETEC Holding or (ii) at any time following the consummation of a Parent Transaction, a majority of the board of directors, board of managers
or other governing body of the corporation or other Person whose Voting Securities are issued to the Existing Stockholders in such transaction; provided, however, that any individual becoming a member of the Board or of such board of
directors, board of managers or other governing body, as the case may be, subsequent to the date of this Agreement whose appointment or nomination for election was approved by a vote of at least a majority of the Incumbent Board Members shall be
deemed to be an Incumbent Board 

  

 2 

	 	 
Member for purposes of this clause (e), but excluding, for such purposes, any such individual whose initial assumption of office occurs as a result of an
actual or threatened election contest with respect to the election or removal of directors (or managers or other members of any such governing body) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other
than the Board or such board of directors, board of managers or other governing body, as the case may be. 

 “Code” shall mean the Internal Revenue Code of 1986, as amended, as in effect on the date hereof or as hereafter amended. 
 “Company” shall mean (a) collectively, PAETEC Holding and its Subsidiaries, or (b) when express reference in this Agreement is made to your employment with the Company or when reference in this Agreement is made
to any notice or other communication you are required or permitted to provide hereunder, PAETEC Holding, if you are employed by PAETEC Holding, or any Subsidiary of PAETEC Holding, if you are employed by such Subsidiary, and shall include the
successors and assigns of PAETEC Holding and each Subsidiary. 
 “Company’s Business” shall mean the businesses in
which PAETEC Holding and its Subsidiaries engage or plan to engage (even if they have not yet begun to engage in such businesses) at any time during the term of your employment with the Company, which businesses shall include research, development,
manufacture, sale, resale and/or licensing of products and services related to communications, integrated communications, long-distance services, Internet access, eCommerce, hardware and software (whether owned or licensed by the Company), wireless
networking and wireless last mile services, and data services, on a wholesale, resale and/or retail basis, including local, domestic, and international long-distance services, local exchange services, IP/ISP services, high-speed Internet access,
MPLS services, DSL services, eCommerce, web hosting, ASP services, data networking, systems integration services, telecommunications hardware manufacturing and sale, internet telephony (VOIP) equipment and services, telecommunications expense
management software and managed services, and data communications services. 
 “Disability” shall mean your “permanent
and total disability” within the meaning of Section 22(e)(3) of the Code. 
 “Exchange Act” shall mean the
Securities Exchange Act of 1934, as amended, as in effect on the date hereof or as hereafter amended. 
 “Existing
Stockholders” shall mean, with respect to any transaction, all holders of all classes of Voting Securities of PAETEC Holding as of the time immediately preceding the consummation of such transaction. 
 “Good Reason” shall mean termination of your employment with the Company due to any of the following: (a) any action by the Company
to reduce your base salary by a material amount at any time; (b) any action by the Company to reduce your “target” 

  

 3 

 
annual bonus opportunity (as opposed to your minimum or maximum annual bonus opportunity), expressed as a percentage of your annual base salary, by a
material amount at any time; or (c) a requirement by the Company that you be based anywhere other than within 50 miles of your current location without your consent; provided, however, you must give written notice to the Company
within 90 days of the occurrence of the condition that is the basis for such Good Reason; provided, further, that, if the basis for such Good Reason is correctible and the Company has corrected the basis for such Good Reason within 30
days after receipt of such notice, you may not then terminate your employment for Good Reason with respect to the matters addressed in such notice, and therefore your notice of termination with respect to such basis for Good Reason shall
automatically become null and void. 
 “Incumbent Board Members” shall mean the individuals who, as of the date of this
Agreement, constitute the Board. 
 “Person” shall mean an individual, a corporation, a partnership, a limited liability
company, an association, a trust or any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. 
 “Subsidiary” shall mean any corporation, partnership, limited liability company, association or other business entity of which more than 50% of the voting power of the outstanding Voting Securities is
owned, directly or indirectly, by PAETEC Holding and one or more other Subsidiaries of PAETEC Holding. 
 “Voting
Securities” shall mean, with respect to any Person, capital stock of any class or kind ordinarily having the power to vote for the election of directors, managers or other voting members of the governing body of such Person. 
  

	2.	Confidentiality 

 (a) You acknowledge that you have
been and shall be provided access to the Company Confidential Information and occupy and shall occupy a position of trust and confidence with respect to the Company’s affairs and business. For purposes of this Agreement, “Company
Confidential Information” shall have the meaning ascribed to such term on Annex A-1 attached hereto and made a part hereof. 
 (b) You acknowledge and agree that: (i) during your employment with the Company, you shall have access to and become acquainted with the Company Confidential Information and materials, including its trade secrets, and shall occupy a
position of trust and confidence with respect to the Company’s affairs, business and customer goodwill, and the Company Confidential Information; (ii) the interests afforded protection by this Agreement are the Company’s legitimate
business interests, deserving of protection; and (iii) the Company would not have entered into or continued its employment relationship with you without your execution of this Agreement. You agree to take the steps set forth on Annex
A-2 attached hereto and made a part hereof to preserve the confidential and proprietary nature of the Company Confidential Information and materials and to preserve the Company’s goodwill. 
  

 4 

	3.	Non-Competition and Non-Solicitation 

 (a) Unless
the following covenants are waived in whole or in part by the Company in accordance with Section 7, for a period of one (1) year after the effective date of termination of your employment with the Company (the “Termination Date)
(irrespective of the reason for, or manner of, such termination), you shall not, directly or indirectly: 
  

	 	(i)	solicit, recruit or hire, or in any manner assist in the soliciting, recruitment or hiring of (A) any of the employees of PAETEC Holding or any Subsidiary or any individuals
who were employed by PAETEC Holding or any Subsidiary within 12 months before the Termination Date, or (B) any of the sales agents or independent sales agents of PAETEC Holding or any Subsidiary, or any individual or Person that was a sales
agent or independent sales agent of PAETEC Holding or any Subsidiary within 12 months before the Termination Date; 

  

	 	(ii)	individually or as an officer, director, employee, shareholder or equity owner (other than as a shareholder or other equity owner of less than 1% of the outstanding capital stock of
a publicly traded company), consultant, contractor, partner, joint venturer, agent, manager, or other representative, work for, become employed by or perform services for any corporation or other Person that is competitive with the Company’s
Business or that would divert business from PAETEC Holding or any Subsidiary in any geographical area in which PAETEC Holding or any Subsidiary is then conducting operations (such competitive corporation or other Person, an “Other
Enterprise”), provided that you shall not be restricted from working for, becoming employed by or performing services for any Other Enterprise, even if another division, subsidiary or Affiliate of such Other Enterprise is competitive with the
Company’s Business or would divert business from PAETEC Holding or any Subsidiary, so long as you do not perform any services for such division, subsidiary or Affiliate, and provided, further, that you shall not be restricted under this
Section 3(b)(ii) from competing with any business of PAETEC Holding or any Subsidiary if you did not provide any services to such business of PAETEC Holding or such Subsidiary or did not possess or have knowledge of Company Confidential
Information within the 24-month period before the Termination Date; 

  

	 	(iii)	solicit on behalf of any Other Enterprise, or accept on behalf of any Other Enterprise, business from any individual, business or organization that was known by you to be a customer
of PAETEC Holding or any Subsidiary, or identified by PAETEC Holding or any Subsidiary as a prospective customer of PAETEC Holding or such Subsidiary, in each case as of or within 12 months before the Termination Date; or 

 

 5 

	 	(iv)	take any action to influence or attempt to influence customers, prospective customers, vendors or suppliers of PAETEC Holding or any Subsidiary known to you to divert their business
to any Other Enterprise or take any action which is intended, or would reasonably be expected, to affect adversely PAETEC Holding or any Subsidiary, the Company’s Business, the reputation of PAETEC Holding or any Subsidiary, or the relationship
of PAETEC Holding or any Subsidiary with its customers, prospective customers, vendors or suppliers. 

 (b) The parties agree
that if a court of competent jurisdiction finds that any term of this Section 3 is for any reason unenforceable because it is overly broad in scope or duration, such term shall be modified to the minimum extent necessary to make it enforceable.
Further, the covenants in this Section 3 shall be deemed to be a series of separate covenants and agreements, one for each and every region of each state, territory, possession or other political division of the United States of America and
each other political division worldwide. If, in any judicial proceeding, a court of competent jurisdiction shall refuse to enforce any of the separate covenants deemed included herein, then, at the option of the Company, wholly unenforceable
covenants shall be deemed eliminated from this Section 3 for the purpose of such proceeding to the extent necessary to permit the remaining separate covenants to be enforced in such proceeding. In addition, if a court or other enforcement body
finds that any provision of this Section 3 may not be enforced as written because of a public policy, you agree that such court or enforcement body shall modify and construe such provision to permit its enforcement to the maximum extent
permitted by law. 
 (c) You acknowledge the highly competitive nature of the industry in which the Company is involved and further as
follows: (i) your services to the Company are special and unique; (ii) your work for the Company shall allow you access to Company Confidential Information, including trade secrets, and customers; (iii) the Company’s business is
conducted throughout the United States and over the Internet and World Wide Web, enabling the Company and you to regularly provide services to customers nationwide; (iv) PAETEC Holding would not have entered into this Agreement but for the
covenants and agreements contained in this Section 3; and (v) the agreements and covenants contained in this Section 3 are reasonable and are necessary and essential to protect the business, Company Confidential Information, including
trade secrets, and goodwill of the Company. You further acknowledge that this Agreement does not restrict your ability to be gainfully employed, and you acknowledge that the geographic boundaries, scope of prohibited activities, and duration of the
covenants set forth in this Section 3 are reasonable in nature and no broader than are necessary to protect the legitimate business interests of the Company. You agree not to raise any objection to the reasonableness of this Section 3 in
any action or proceeding to enforce the terms of this Agreement. 
  

	4.	Certain IP and Inventions 

 (a) During your
employment with the Company, you agree that you shall not knowingly improperly use or disclose any proprietary information or trade secrets of any 

  

 6 

 
former employer or other Person intended by such employer or other Person not to be disclosed to the Company. You further agree that you shall not bring onto
the Company’s premises any unpublished document or proprietary information belonging to any former employer or other Person unless consented to in writing by such employer or other Person. You agree to inform the Company of any conflicts
between your work for the Company and any obligations you may have to preserve the confidentiality of another Person’s proprietary information or materials. If you do not so inform the Company, the Company may conclude that no such conflicts
exist, and you agree that thereafter you shall make no claim against the Company that any such conflicts exist. The Company shall receive any such disclosures about any such conflicts in confidence and consistent with the objectives of avoiding any
conflict of obligations and rights or the appearance of any conflict of interest. 
 (b) Inventions directly relating and applicable and
useful to the Company’s Business, if any, patented or unpatented, which you made prior to the commencement of your employment with the Company are excluded from the scope of this Agreement. To preclude any possible uncertainty, you have set
forth on Exhibit 1 attached hereto a complete list of all such Inventions that you have, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the
commencement of your employment with the Company, that you consider to be your property or the property of third parties and that you wish to have excluded from the scope of this Agreement (collectively referred to as “Prior Inventions”).
If disclosure of any such Prior Invention would cause you to violate any prior confidentiality agreement, you understand that you are not to list such Prior Inventions in Exhibit 1 attached hereto but are only to disclose a cursory
name for each such invention, a listing of the party or parties to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason. A space is provided on Exhibit 1 attached hereto for such
purpose. If no such disclosure is attached, you represent that there are no such Prior Inventions. If, in the course of your employment with the Company, you incorporate a Prior Invention into a Company product, test, service or process, the Company
is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to sublicense through multiple tiers of sublicensees) to make, have made, modify, use and sell such Prior Invention.
Notwithstanding the foregoing, you agree that you shall not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions without the Company’s prior written consent. 
 (c) You represent that, to the best of your knowledge, your performance of all of the terms of this Agreement and as an employee of the Company does not
and shall not breach any agreement to keep in confidence proprietary information acquired by you prior to your employment by the Company. Further, you represent that, to the best of your knowledge, the performance of your duties with the Company
shall not breach any contractual or other legal obligation you have to any third Person. 
 (d) You agree that any and all intellectual
properties, including all ideas, concepts, themes, inventions, designs, tests, procedures, research methods, improvements, discoveries, developments, formulas, patterns, devices, processes, 

  

 7 

 
software programs, hardware information, engineering and other information related to the integration of hardware and software, software program codes, logic
diagrams, flow charts, decision charts, drawings, procedural diagrams, coding sheets, documentation manuals, technical data, client, customer and supplier lists, and compilations of information, records, and specifications, and other matters
constituting Company Confidential Information (including trade secrets), that relate in any way to the actual or prospective business of the Company or to any experimental or developmental work carried on by the Company, and that are conceived,
developed or written by you, individually or in collaboration with others during your employment, and all designs, plans, reports, specifications, drawings, inventions, processes, test data and/or other information or items produced by you while
performing your duties for the Company, shall belong to and be the sole and exclusive property of the Company, and are “works for hire” by you in your capacity as an employee of the Company. To the extent any such tangible or intangible
work product of yours is not a “work for hire,” you hereby assign and transfer to the Company, to the fullest extent permitted by law, all of your rights, title and interest in such intellectual properties, including all patent, copyright
or trade secret rights therein. 
 (e) You further agree to assist the Company in obtaining patents on all inventions, designs, improvements
and discoveries that are patentable, or copyright registrations on all works of authorship, and to execute all documents and do all things necessary to vest the Company with full and exclusive title and protect against infringement by others. You
agree to give the Company or its designees all assistance reasonably requested to perfect such rights, provided that following termination of your employment, the Company shall reimburse you for your reasonable time and expense in assisting
with such matters. You further agree that if the Company is unable, after reasonable effort, to secure your signature on any such documents, any officer of the Company shall be entitled to execute any such documents as your agent and
attorney-in-fact, and you hereby irrevocably designate and appoint each officer of PAETEC Holding and each Subsidiary as your agent and attorney-in-fact to execute any such documents on your behalf, and to take any and all actions as the Company may
deem necessary or desirable in order to protect its rights and interests in any work, under the conditions described in this sentence. You agree that you shall promptly and fully inform the Company of and disclose to the Company all intellectual
properties described in this Agreement that you make during your employment with the Company, whether individually or jointly in collaboration with others, that pertain or relate to the actual or potential business of the Company or to any
experimental or developmental work carried on by the Company, whether or not conceived during regular working hours. You agree to make full disclosure to the Company immediately after creating or making any of the intellectual properties identified
in this Agreement, and shall thereafter keep the Company fully informed at all times of all progress in connection therewith. You also agree that you shall promptly disclose to the Company all patent applications filed by you or on your behalf
within 12 months after the Termination Date that relate to or concern the Company’s Business. 
 (f) You understand that the term
“moral rights” shall mean any rights of attribution or integrity, including any right to claim authorship of a copyrightable work, 

  

 8 

 
to object to a modification of such copyrightable work, and any similar right existing under the judicial or statutory law of any country in the world or
under any treaty, regardless of whether or not such right is denominated or generally referred to as a “moral right.” You forever hereby waive and agree never to assert any moral rights you may have in any copyrightable work that is a
“work for hire” or is assigned to the Company as a result of this Agreement, even after any termination of your employment with the Company. 
  

	5.	Consideration 

 As consideration for the covenants
set forth in Section 3, the Company agrees as follows: 
 (a) In connection with the termination of your employment with the Company
(irrespective of the reason for, or manner of, such termination), unless your employment is terminated due to your death or Disability, the Company, subject to the Company’s waiver right set forth in Section 7, shall: 
  

	 	(i)	pay you in the form of salary continuation, in equal installments in accordance with Section 6, during the one-year period in which the covenants set forth in Section 3
are in effect, an amount equal to the highest annualized base salary paid to you at any time during the one-year period immediately preceding the termination of your employment (hereafter referred to as your “Base Salary”), provided
that, if your employment is terminated by the Company without Cause or by you for Good Reason within one year following the consummation of a Change of Control Transaction, then the Company shall pay you during the one-year period in which the
covenants set forth in Section 3 are in effect, an amount equal 1.5 times your Base Salary; 

  

	 	(ii)	subject to the Company’s ability to do the same in accordance with the terms of the applicable program documents and applicable law, as determined by the Company in good faith,
continue your eligibility and participation in the following benefit programs: 

  

	 	(A)	 if you choose to enroll in continued medical and/or dental plan coverage for which you are eligible pursuant to the Consolidated Omnibus Budget Reconciliation Act
(“COBRA”) and you actually enroll within the applicable statutory period, the Company shall pay a portion of the premiums for such coverage in an amount equal to the amount of the premiums it paid on your behalf for coverage in such plans
immediately prior to your termination of employment (which payments shall be includible in your taxable income) until the earliest to occur of (x) the date of termination of the one-year period during which the covenants set forth in
Section 3 are in effect, (y) the date on which COBRA 

  

 9 

	 	 
benefits cease to be available to you under applicable law or (z) the date on which you enroll in another medical plan (and if the payments the Company
makes on your behalf under this provision cease prior to the date on which any entitlement you may have to continuation of health insurance coverage ceases under applicable law, you may continue to participate in such coverage thereafter at your
expense to the extent provided under any applicable law); and 

  

	 	(B)	during the entire one-year period in which the covenants set forth in Section 3 are in effect, the Company shall pay the premiums (on a semi-annual basis) for the
Company-provided life insurance you elect to “port” following your termination of employment (and you shall be able to continue any supplemental life insurance coverage at your own expense following separation from the Company).

 (b) If your employment with the Company is terminated by you for Good Reason or by the Company without Cause, the Company,
subject to the Company’s waiver right set forth in Section 7, shall pay you on account of the annual bonus period ending during the one-year period in which the covenants set forth in Section 3 are in effect, in accordance with
Section 6, an annual bonus amount equal to the lesser of (i) the “target” amount that you would have been eligible to receive under the Company’s annual bonus plan for corporate non-commissioned employees (the “Annual
Bonus Plan”) in effect on the Termination Date, as if such annual bonus year had been completed and your particular bonus targets had been fully achieved at the “target” level (as opposed to the maximum level), or (ii) if the
amount achieved is less than the “target” level, the amount that is achieved, or to the extent that no bonus is achieved, no amount shall be paid provided that, if your employment is terminated by the Company without Cause or by you
for Good Reason within one year following the consummation of a Change of Control Transaction, then the foregoing subsection (ii) provisions shall not apply and the “target” level bonus shall be paid. For purposes of applying this
subsection, the bonus payment shall be applied as if you had been an employee of the Company during the entire applicable bonus year (i.e., the payment shall not be pro-rated in any manner) and any requirements of the Annual Bonus Plan that you be
employed by the Company during all of the calendar year covered by the Annual Bonus Plan and/or be on the payroll as of the date on which the bonus payments are actually paid out shall not apply for the purposes of the entitlement under this
Section 5. 
 (c) PAETEC Holding shall provide in each agreement evidencing awards of stock options, stock appreciation rights,
restricted stock, stock units or other equity-based awards granted to you on or after the date of this Agreement (collectively, the “Applicable Awards”) that: 
  

	 	(i)	 if your employment with the Company is terminated by you for Good Reason or by the Company without Cause, the Applicable Awards shall continue to vest over the
entire one-year period in which the 

  

 10 

	 	 
covenants set forth in Section 3 are in effect as if your employment with the Company had continued over such period (with the last day on which the
covenants set forth in Section 3 are in effect being deemed to be your last day of employment with the Company for purposes of determining the expiration date of your Applicable Awards); and 

  

	 	(ii)	(A) immediately prior to the consummation of a Change of Control Transaction, all restricted stock, stock units and similar awards that are Applicable Awards held by you shall vest
and the shares of stock subject thereto shall be delivered to you, and (B) 15 days prior to the scheduled consummation of a Change of Control Transaction, all stock options, stock appreciation rights and similar awards that are Applicable
Awards shall become immediately exercisable and shall remain exercisable until such consummation. 

 (d) Notwithstanding
anything in this Agreement to the contrary, the following benefits shall cease as of the Termination Date: (i) your contributions and contributions on your behalf to the Company-sponsored Code Section 401(k) plan, and any other retirement
plan maintained by the Company; (ii) your coverage under the Company’s short-term and long-term disability policies; and (iii) your coverage under all other benefit programs. 
 (e) Nothing in this Section 5 or otherwise in this Agreement shall be construed to impose an obligation on the Company to continue your employment
or retain you in any capacity after the Termination Date. 
  

	6.	Payment Procedures; Forfeiture of Payments 

 (a)
Payment equal to the amount of your Base Salary pursuant to Section 5 shall be made in installments in accordance with the Company’s customary payroll practices, except that the Company shall have no obligation to accommodate your request
for direct deposit or voluntary deductions for any purpose. In those years, if any, in which you are entitled to receive a multiple of your annualized Base Salary, each regular payroll payment that is due to you shall be based upon such multiple, so
that all regular payroll payments in such year are as nearly equal in amount as reasonably practicable. 
 (b) Payment of amounts equal to
the annual bonus amounts pursuant to Section 5 shall be made in accordance with the Company’s customary annual bonus payout practices (including, to the extent applicable, “progress” or similar payments for the annual bonus
period ending during the period in which the covenants set forth in Section 3 are in effect). The first installment of such payments shall be made on the first regular payroll date of the Company after the Effective Date (as such term is
defined in Section 6(g)) of the release referred to in Section 6(g) (the “Release”). Without limiting the foregoing, payment of such amounts shall be made to you at the same time and in the same manner as the annual bonus is paid
out to the Company’s employees generally, and, in any event, payments other than “progress” payments shall be made in the calendar year 

  

 11 

 
immediately following the calendar year in which the applicable bonus year occurs, except that in any year in which there is no bonus payout to employees
generally, the annual bonus amount due to you shall be paid to you in full no later than February 1 of the calendar year immediately following the calendar year in which the applicable bonus year occurs, but in no event prior to the Effective
Date of the Release. If the Effective Date of the Release has not occurred on or prior to the later of December 31 of the calendar year in which the foregoing payments otherwise would have been made or the 40th day after the Termination Date, you shall forfeit any payments that would have been made in such calendar year if the Effective Date of the Release had occurred on the
40th day after the Termination Date. 
 (c) If the Company determines in good faith that you have violated the terms of any of the covenants set forth in this Agreement, the Company, in addition to any other remedies available under law, may discontinue any payments being made to
you, and may discontinue any other benefits to which you otherwise are entitled, pursuant to Section 5. 
 (d) If as a result of any
legal challenge by you: 
  

	 	(i)	a court of competent jurisdiction determines the provisions of Section 3 to be void or unenforceable in whole or in part, the Company, in its absolute discretion, may terminate
the payments and benefits set forth in Section 5 as of the effective date of the court judgment; or 

  

	 	(ii)	a court of competent jurisdiction determines that your obligations under Section 3 are valid and enforceable for a period shorter than the entire period provided for in
Section 3, the Company’s obligations under Section 5 shall continue only for the period for which it is determined by such court that such covenants may be enforced (with any amounts payable by the Company, and any continued vesting,
being reduced on a proportionate basis). 

 (e) Anything in this Agreement to the contrary notwithstanding, if (i) on the
Termination Date, any capital stock of PAETEC Holding or any successor thereto is publicly traded on an established securities market or otherwise (within the meaning of Section 409A(a)(2)(B)(i) of the Code), (ii) you are determined to be
a “specified employee” within the meaning of Section 409A(a)(2)(B) of the Code, (iii) the payments exceed the amounts permitted to be paid pursuant to Treasury Regulations section 1.409A-1(b)(9)(iii) and (iv) such delay is
required to avoid the imposition of the tax set forth in Section 409A(a)(1) of the Code, as a result of the termination of your employment, you would receive any payment that, absent the application of this Section 6(e), would be subject
to interest and additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(2)(B)(i) of the Code, then no such payment shall be payable prior to the date that is the earliest of
(A) six months after the Termination Date, (B) the date of your death or (C) such other date as shall cause such payment not to be subject to such interest and additional tax (with a catch-up payment equal to the sum of all amounts
that have been delayed to be made as of the date of the initial payment). 
  

 12 

 With respect to payments under this Agreement, for purposes of Section 409A of the Code, each
severance payment and COBRA continuation reimbursement payment shall be considered one of a series of separate payments. Any amount for which you are entitled to be reimbursed by the Company shall be reimbursed to you as promptly as reasonably
practicable and in any event not later than the last day of the calendar year in which the reimbursable expenses are incurred, and the amount of such expenses eligible for reimbursement during any calendar year shall not affect the amount of
expenses eligible for reimbursement in any other calendar year. It is the intention of the parties that payments or benefits payable under this Agreement not be subject to the additional tax imposed pursuant to Section 409A of the Code. To the
extent such potential payments or benefits could become subject to Section 409A of the Code, the parties shall cooperate to amend this Agreement with the goal of giving you the economic benefits provided for herein in a manner that does not
result in such tax being imposed. 
 (f) A termination of employment under this Agreement shall be deemed to occur only in circumstances that
would constitute a termination of employment for purposes of Treasury Regulations section 1.409A-1(h)(1)(ii). 
 (g) Notwithstanding anything
in this Agreement to the contrary, as a condition to the Company’s obligation to pay any form of severance or other amount to you or on your behalf upon or following the termination of your employment with the Company, you shall at the time of
such termination, execute and deliver to the Company (and shall fail to revoke within such time period as may be established by law (the last day of such time period, the “Effective Date”)) a full and unconditional release in favor of the
Company and its Affiliates of all obligations other than those set forth in this Agreement, in form and substance satisfactory to the Company. 
  

	7.	Waiver 

 The Company may waive your compliance in
whole or in part with one or all of the covenants set forth in Section 3 at its sole discretion if your employment is terminated for Cause. Such a waiver must be made in writing duly executed by PAETEC Holding or any Subsidiary that employs you
and shall not in any way be deemed a waiver of the Company’s right to enforce any other requirements or provisions of this Agreement. You acknowledge that, if the Company so waives the covenants set forth in Section 3 in whole following
the termination of your employment for Cause, the Company shall not be obligated to pay you any of the consideration (including non-cash benefits) set forth in Section 5, notwithstanding any provision of this Agreement to the contrary.

  

	8.	“At Will” Nature of Relationship 

 Nothing
in this Agreement shall be construed as constituting an agreement, understanding or commitment of any kind that the Company shall continue to employ you for any period of time. You hereby acknowledge and agree that your employment with the Company
is and shall be “at will,” terminable by you or by the Company at any time with or without cause and with or without notice. 
  

 13 

	9.	Enforcement 

 You acknowledge and agree that the
restrictions contained in this Agreement are reasonable and necessary to protect the business, Company Confidential Information (including trade secrets), goodwill and other interests of the Company and that any violation of these restrictions would
cause the Company substantial irreparable injury. Accordingly, you agree that a remedy at law for any breach of the covenants or other obligations in this Agreement would be inadequate and that the Company, in addition to any other remedies
available, shall be entitled to obtain preliminary and permanent injunctive relief to secure specific performance of such covenants and to prevent a breach or threatened breach of this Agreement without the necessity of proving actual damage and
without the necessity of posting bond or security, which you expressly waive. You shall provide the Company a full accounting of all proceeds and profits received by you as a result of or in connection with a breach of this Agreement. Unless
prohibited by law, the Company shall have the right to retain any amounts otherwise payable by the Company to you to satisfy any of your obligations as a result of any breach of this Agreement. You hereby agree to indemnify and hold harmless the
Company from and against any damages incurred by the Company as assessed by a court of competent jurisdiction as a result of any breach of this Agreement by you. You agree that each of your obligations specified in this Agreement is a separate and
independent covenant that shall survive termination of your employment for any reason and that the unenforceability of any covenant in this Agreement shall not preclude the enforcement of any other covenants in this Agreement. 
  

	10.	Notification of New Employer 

 In the event that you
leave the employ of the Company, voluntarily or involuntarily, you agree to inform any subsequent employer of your rights and obligations under this Agreement. You further hereby authorize the Company to notify any future employer of your rights and
obligations under this Agreement. The foregoing consent is limited to the delivery by the Company to any future employer a signed copy of this Agreement, and any written modifications thereto, and not to any characterization thereof by the Company.

  

	11.	Successors and Assigns 

 This Agreement shall be
binding upon and inure to the benefit of both parties and their respective successors and assigns, including any corporation or other Person with which or into which PAETEC Holding or any Subsidiary may be merged or which may succeed to the assets
or business of PAETEC Holding or such Subsidiary, including in a Change of Control Transaction, provided, however, that your obligations as an employee of the Company, are personal and shall not be assigned by you. Without limiting the
generality of the foregoing, PAETEC Holding shall have the right, in its discretion, to assign this Agreement to any Subsidiary for purposes of the enforcement of this Agreement. 
  

 14 

	12.	General Terms 

 (a) Except as set forth in
Section 12(b), this is your entire agreement with the Company with respect to its subject matter, superseding any prior oral or written, express or implied negotiations and agreements. This Agreement may not be changed in any respect except by
a written agreement signed by both you and the Company. If any provision of the Agreement is held to be invalid, illegal or unenforceable for any reason, the validity, legality and enforceability of the remaining provisions shall not in any way be
affected or impaired thereby, except to the extent expressly provided in Section 6(d) or otherwise required by applicable law. The delay or omission by the Company or you in exercising its/your rights under this Agreement, or the failure of
either party to insist on strict compliance with any of the terms, covenants, or conditions of this Agreement by the other party, shall not be deemed a waiver of any terms, covenants or conditions of this Agreement, nor shall any waiver or
relinquishment of any right or power at any one time or times be deemed a waiver or relinquishment of that right or power for all times or any other time. The captions of the sections of this Agreement are for convenience of reference only and in no
way define, limit or affect the scope or substance of any section of this Agreement. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same
instrument. It is the express intention and agreement of the parties hereto that all covenants, agreements and statements made by any party in this Agreement shall survive the execution and delivery of this Agreement. In addition, the covenants,
agreements and statements made in this Agreement shall survive termination of your employment with the Company for any reason. 
 (b) (i)
Except as expressly provided in Section 12(b)(ii), any Senior Officer Confidentiality, Non-Solicitation, Non-Competition and Severance Agreement or Senior Vice President Confidentiality, Non-Solicitation and Non-Competition Agreement or similar
agreement to which you are a party immediately prior to the effectiveness of this Agreement (collectively, the “Prior Agreement”) hereby automatically and without any further action by any party thereto terminates and is of no further
force or effect. 
 (ii) Notwithstanding any other provision of this Agreement, it is the intention of the parties to preserve the vesting of
the stock options and restricted stock units that were awarded to you prior to the date of this Agreement (the “Subject Awards”) on the same terms and conditions that governed such vesting immediately prior to the execution and delivery of
this Agreement, provided that the continued vesting of the Subject Awards following the termination of your employment shall be subject to your compliance with the covenants set forth in Section 3(a) of this Agreement rather than your
compliance with any corresponding covenants in any Prior Agreement and any other agreements relating to the Subject Awards (such other agreements together with any Prior Agreement, the “Subject Award Agreements”). Consistent with the
foregoing, the provisions of the Subject Award Agreements that provide for continued vesting of the Subject Awards following the termination of your employment upon specified 

  

 15 

 
circumstances (A) shall continue in full force and effect solely to the extent required to effectuate the intention of the parties to this Agreement as
specified in the preceding sentence of this Section 12(b)(ii) and (B) shall be deemed to be amended by this Agreement so that any references therein to a non-competition covenant to which continued vesting of the Subject Awards is subject
shall be deemed to be a reference to the covenants set forth in Section 3(a) of this Agreement. 
 (c) The use in this Agreement of the
word “include” or “including,” when following any general statement, term or matter, shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to
similar items or matters, whether or not nonlimiting language (such as “without limitation” or “but not limited to” or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other
items or matters that fall within the broadest possible scope of such general statement, term or matters, unless such term relates to a period of time. 
  

	13.	Understanding and Authority 

 You understand and
agree that all terms of this Agreement are contractual and not a mere recital, and represent and warrant that you are competent to covenant and agree as herein provided. You represent and warrant that in negotiating and executing this Agreement, you
have had an adequate opportunity to consult with competent legal counsel of your choosing concerning the meaning and effect of each term and provision hereof. You represent that you have carefully read this Agreement in its entirety, fully
understand and agree to its terms and provisions, and intend and agree that it be final and binding. 
  

	14.	Applicable Law 

 EXCEPT AS OTHERWISE EXPRESSLY
PROVIDED FOR IN THIS AGREEMENT, THIS AGREEMENT AND ITS TERMS WILL BE CONSTRUED IN ACCORDANCE WITH, AND ENFORCED AND GOVERNED BY, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OR CHOICE OF LAW RULES OR OTHER PRINCIPLES THAT MIGHT
OTHERWISE REFER CONSTRUCTION OR INTERPRETATION OF THIS AGREEMENT TO THE SUBSTANTIVE LAW OF A JURISDICTION OTHER THAN NEW YORK. 
  

	15.	Forum Selection, Jury Waiver, Service of Process 

 AT ALL TIMES EACH PARTY HERETO: (A) IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY NEW YORK COURT OR FEDERAL COURT SITTING IN NEW YORK; (B) AGREES THAT ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY SHALL BE HEARD AND DETERMINED IN SUCH NEW YORK STATE OR FEDERAL COURT; (C) TO THE EXTENT PERMITTED BY LAW, IRREVOCABLY WAIVES (I) ANY OBJECTION SUCH PARTY MAY HAVE TO THE LAYING OF VENUE OF
ANY SUCH ACTION 

  

 16 

 
OR PROCEEDING IN ANY SUCH COURT, OR (II) ANY CLAIM THAT SUCH PARTY MAY HAVE THAT ANY SUCH ACTION OR PROCEEDING HAS BEEN BROUGHT IN AN INCONVENIENT
FORUM; (D) TO THE EXTENT PERMITTED BY LAW, IRREVOCABLY AGREES THAT A FINAL NONAPPEALABLE JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER
PROVIDED BY LAW; AND (E) IRREVOCABLY WAIVES TRIAL BY JURY AS TO ANY ACTION, MATTER, CLAIM OR ISSUE ARISING BETWEEN THEM RELATING TO THIS AGREEMENT, ITS ENFORCEMENT OR BREACH. 
 NOTHING IN THIS SECTION 15 SHALL AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE LEGAL PROCESS IN ANY MANNER PERMITTED BY LAW. FURTHER, YOU AGREE THAT
SERVICE OF PROCESS MAY BE MADE BY CERTIFIED MAIL AT YOUR ADDRESS LAST KNOWN TO THE COMPANY. 
 [signature page follows] 
  

 17 

 By your signature below, you acknowledge that you have reviewed this Agreement carefully and understand
that the covenants and obligations it contains are binding on you. 
 IN WITNESS WHEREOF, the parties hereto have executed and delivered this
Agreement as of the      day of             , 20    . 
  

			
	 EXECUTIVE

		
	 Signature:
	 	  

	 Printed Name:
	 	  

	 Home Address:
	 	  

  

			
	 PAETEC HOLDING CORP.

		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

  

 18 

 Annex A-1 
 Company Confidential Information 
 For purposes of this Agreement, the following materials and
information, whether having existed, now existing, or to be developed or created during the term of your employment by the Company, constitute “Company Confidential Information” that is subject to this Agreement: 
 1.1. Products and Services. All information to which the Company gave me access, all information disclosed to me by the Company, and all
information developed for the Company by me, alone or with others, that directly or indirectly relates to the business, products and/or services that the Company engages in, plans to engage in or contemplates engaging in, including research,
development, manufacture, sale and/or licensing of products and services related to communications, integrated communications, long-distance services, Internet access, eCommerce, hardware and software (whether owned or licensed by the Company),
wireless networking and wireless last-mile services, and data services, on a wholesale, resale and/or retail basis, including but not limited to local, domestic, and international long-distance services, local exchange services, IP/ISP services,
high-speed Internet access, MPLS services, DSL services, eCommerce, web hosting, ASP services, data networking, systems integration services, internet telephone (VOIP) equipment and services, telecommunications expense management software and
managed services, and data communications services and other proprietary products or services, whether existing or in any stage of research and development (such as trade secrets, inventions, ideas, methods, technical and laboratory data,
engineering data and information, engineering information related to the integration of communications devices and equipment, benchmark test results, processes, design specifications, algorithms, technical data, technical formulas, engineering data,
processes, manufacturing data, procedures, techniques, methodologies, information processing processes, and strategies). 
 1.2. Business
and Marketing Procedures and Customer Information. All information concerning or relating to the way the Company conducts its business, markets its products and services, and all information relating to any Company customers and sales agents or
prospective customers and sales agents (such as internal business procedures, business strategies, marketing plans and strategies, controls, plans, licensing techniques and practices, supplier, subcontractor and prime contractor names and contracts
and other vendor information, customer information and requirements, sales agent information, computer system passwords and other computer security controls, financial information, distributor information, information supplied by clients and
customers of the Company and employee data). 
 1.3. Not Generally Known. Any information in addition to the foregoing which is not
generally known to the public or within the industry or trade areas in which the Company competes, through no fault of mine, which gives the Company any advantage over its competitors. 
 1.4. Third-Party Information. Any information that is confidential and proprietary to a third party that the Company has and in the future will
receive from such third party subject to the Company’s duty to maintain the confidentiality of such information and to use it for certain limited purposes. 
  

 A-1-1 

 1.5. All Physical Embodiments of Products, Services, Business, Marketing, Customer and Other
Information. All the physical embodiments of all of the information included in Sections 1.1, 1.2, 1.3 and 1.4 of this Annex A-1, including research programs, research data, testing data, software, compositions, compounds, hardware, works
of authorship, source code, other computer code, correspondence, check lists, samples, forms, ledgers, financial data, financial statements, financial reports, forecasts and projections, discounts, margins, costs, credit terms, pricing practices,
pricing policies and procedures, goals and objectives, quoting practices, quoting procedures and policies, financial and operational analyses and studies, management reports of every kind, databases, employment records pertaining to employees other
than yourself, customer data including customer lists, contracts, representatives, requirements and needs, specifications, data provided by or about prospective, existing or past customers and contract terms applicable to such customers, engineering
notebooks, notes, drawings, work sheets, schematics, load modules, schematics, annotations, flow charts, logic diagrams, procedural diagrams, coding sheets, requirements, proposals, instructor manuals, course materials, video cassettes,
transparencies, slides, presentations, proposals, printouts, studies, contracts, maintenance manuals, operational manuals, documentation, license agreements, marketing practices, marketing policies and procedures, marketing plans and strategies,
marketing reports, strategic business plans, marketing analyses, seminar and class attendee rosters, trade show or exhibit attendee listings, listings of customer leads, and any other written or machine-readable expressions of such information as
are fixed in any tangible media. 
 1.6. Trade Secrets. I acknowledge and agree that the Company Confidential Information identified
in Sections 1.1, 1.2, 1.3 and 1.5 of this Annex A-1 constitute trade secrets of the Company. 
 1.7. Excluded Matters. The general
skills, knowledge and experience gained during your employment with the Company, and information publicly available or generally known within the industry or trade areas in which the Company competes, are not considered Company Confidential
Information. 
  

 A-1-2 

 Annex A-2 
 Obligations With Respect to Company Confidential Information 
 1.1. Non-Disclosure. During and
after your employment with the Company, you shall not misuse, misappropriate, disclose or transfer in writing, orally or by electronic means, any Company Confidential Information, directly or indirectly, to any other Person, or use Company
Confidential Information in any way, except as is required in the course of your employment with the Company, nor shall you accept any employment or other professional engagement that likely shall result in the use or disclosure, even if
inadvertent, of Company Confidential Information. You further agree that Company Confidential Information includes information or material received by the Company from others, including its Affiliates, and is intended by the Company to be kept in
confidence by its recipients. You understand that you are not allowed to sell, license or otherwise exploit any products (including hardware or software in any form) which embody or otherwise exploit in whole or in part any Company Confidential
Information or materials. You acknowledge and agree that the sale, misappropriation, or unauthorized use or disclosure in writing, orally or by electronic means, at any time of Company Confidential Information obtained by you during the course of
your employment constitutes unfair competition. You agree and promise not to engage in any unfair competition with the Company, either during your employment or at any other time thereafter. You further acknowledge and agree that the Company’s
products and services can be developed and marketed nationwide, and therefore, the protection afforded the Company must likewise be nationwide. 
 1.2. Preservation, Removal and Return of Information. You agree to take all reasonable steps to preserve the confidential and proprietary nature of Company Confidential Information and to prevent the inadvertent or accidental
disclosure of Company Confidential Information. You acknowledge and agree that all Company Confidential Information, whether prepared by you or otherwise coming into your possession while you are employed by the Company, shall remain the exclusive
property of the Company. You agree that during your employment with the Company and thereafter, you shall not use, disclose, transfer, or remove from the Company’s premises any Company Confidential Information other than as authorized by the
Company. You agree to return to the Company all Company Confidential Information and copies thereof, in whatever form, at any time upon the request of the Company, and at the time of your termination of employment for any reason. You agree not to
retain any copies of any Company Confidential Information or Company-owned materials after your termination of employment for any reason whatsoever. Your obligations under Section 2 of the Agreement (including this Annex A-2) shall continue
after termination of your employment with the Company. 
  

 A-2-1 

 Exhibit 1 
 PRIOR INVENTIONS 
 This Exhibit 1 sets forth a complete list of all Inventions that I, alone or
jointly with others, have conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my employment with the Company, that I consider to be my property or the property of third
parties and that I wish to have excluded from the scope of the Executive Confidentiality, Non-Solicitation, Non-Competition and Severance Agreement (collectively referred to as “Prior Inventions”). 
 I understand that if disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I am not to list such Prior
Inventions in this Exhibit 1 but am only to disclose a cursory name for each such invention, a listing of the party or parties to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason. A space is
provided below for such purpose. 
 If no such disclosure is attached, I represent that there are no Prior Inventions. 
 Description of Prior Inventions And Related Documents (if applicable): 
  

							
	 Title and Description of
 Invention
And Related
 Document
	  	Date of
Invention/
Document	  	 Owners of
 Invention/Document
	  	Name of
Witness(es) to
Invention/
Document
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	

 If no information is listed herein, I hereby affirm that I do not have any such prior intellectual
properties, inventions or other works to identify. 
  

			
	 Signature
	 	  

	 Name
	 	  

	 Date
	 	  

  

 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]